Fluoxetine for Visual Recovery After Ischemic Stroke
NCT02737930
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
17
Enrollment
OTHER
Sponsor class
Stopped
Slow recruitment and lack of funding to expand to other sites.
Conditions
Acute Stroke
Visual Field Loss
Interventions
DRUG:
Fluoxetine
DRUG:
Placebo
Sponsor
Bogachan Sahin